Vivax Announces the Promotion of Two Key Executives

Susanne Tavares has been promoted to Vice President of Business Operations. Susanne came to Vivax two and a half years ago. She had many years of successful accounting and business management prior to joining Vivax and has excelled in her positions here. Susanne has completely redesigned all business processes from ordering to billing, implemented new software and accounting procedures, developed our online ordering process and has increased efficiency and profitability significantly. We look forward to her ongoing achievements and wish her all the best in her new position.

Brian DeRosa has been promoted to Senior Director of Technical Operations. Brian has been at Vivax for almost 6 years and has held positions of increasing responsibility. Brian has implemented completely new operation processes and to date opened three new corporate distribution centers. His efforts have contributed to increased efficiency and profitability along with maintaining outstanding customer service relationships with our partner hospitals. We look forward to his continued achievement and wish Brian all the best in his new position.

 

Press Release for Immediate Release

FOR IMMEDIATE RELEASE
Monday, August 5, 2013
FOR IMMEDIATE RELEASE
CONTACT:   Kim Gay, iGuard PPC                                      

EMAIL:   kim@iguardppc.com

iGuard PPC Partners with Vivax Medical

iGuard PPC is pleased to welcome Vivax Medical Corporation as its exclusive customer for Bed Enclosure protection.  iGuard and  Vivax Medical have partnered to help address the growing issue of healthcare acquired infections (HAI). The iGuard antimicrobial coating creates a self-sanitizing surface to protect the enclosure systems.   

Vivax Medical is the manufacturer of the Soma® Safe Enclosure System. The Soma® provides a safe, humane and relaxing environment for behaviorally challenged patients that otherwise would have required a less humane and more restrictive restraint option.  The Soma® Safe Enclosure allows patients to do everything they normally do in a standard hospital bed except exit unassisted – thus preventing bed exit falls. Vivax Medical is the longest tenured manufacturer of enclosure beds in the world. They have the first and largest evidence based data validation system, which documents the outcomes related to the Soma® Safe Enclosure. For the past 15 years, Vivax Medical has dedicated its resources to continuously improving the Soma® Safe Enclosure. Vivax takes safety very seriously that is why they have added iGuard’s antimicrobial coating to the Soma® Enclosure frame and netting to create a self-sanitizing surface.  The coating adds another layer of protection against harmful pathogens.

“Vivax Medical Corporation’s core value is commitment to patient safety.  Given the healthcare mandate to reduce never events, Vivax has partnered with iGuard to protect patients from hospital acquired infections (HAI’s) by applying the iGuard antimicrobial coating to all of our Soma® devices.  The iGuard coating creates a self-sanitizing surface which prevents growth of microorganisms and helps prevent HAI’s.  This application will help us maintain our lead in patient safety. We thank iGuard for this exclusive opportunity” said Rick Swanson, Vivax’s CEO.

When you stop to consider it, the prevalence of healthcare-acquired infections makes sense and can seem inevitable. Healthcare facilities house large numbers of sick people, some with infectious diseases and many with poorly functioning immune systems. These infections are caused by bacteria or viruses. Frighteningly, many of them are caused by multidrug-resistant superbugs.

“Vivax Medical’s addition of iGuard’s antimicrobial coating demonstrates that the patient and staff’s health is their top priority. It provides additional protection against dangerous pathogens and when you have so many hospitals and patients depending on you, it really just makes good business sense,” said Kim Gay the CEO of iGuard PPC.

When you or a loved one heads to the hospital, the last thing you want to worry about is a secondary infection. Yet, the truth is every year in the US over 2 million people go into hospitals and get sick with a healthcare-acquired infection.

For many, (like the elderly, the weak or the very young), these infections can be deadly; over 100,000 patients die from these infections each year – more than car accidents, breast cancer and AIDS combined – according to the Committee to Reduce Infection Deaths (RID). These infections are also expensive. It has been estimated that patients who contract an infection in the hospital, stay an average of 21 days, compared with just 4.5 days for other patients, and their hospital stays cost six times more. As if that weren’t enough, in 2012, Medicare, stopped paying hospitals to treat several types of hospital infections that are preventable and therefore should “never” happen.

Vivax Medical Corporation announces our newest hospital – The Stamford Hospital

Vivax Medical Corporation welcomes Stamford Hospital in Stamford CT!  Stamford is joining the many hospitals currently served by Vivax in CT.  We will begin education and implementation shortly and will be providing around the clock training to the staff.  Vivax will service Stamford from our Naugatuck CT headquarters.  Welcome Stamford!

From a Certified Soma Safe Hospital

The Soma® Safe Enclosure Bed has been utilized on the Geriatric Psychiatric Unit since May, 2007 with acceptance and positive responses from staff, patients and families. There have been no adverse patient outcomes. We attribute the successful integration of the Soma® Safe Enclosure Bed as a safe, less restrictive safety intervention to the development of the education program that was initially provided to staff and physicians.

This program was specifically designed to promote discussion and challenge unfounded beliefs and in turn enhance the staff’s ability to adequately address patient and family concerns regarding the use of the bed. The educational program addressed the following concerns and is additionally supported by the nursing policy identifying the criteria for appropriate use of the Soma® Safe Enclosure Bed and written patient/family education material:

  • The Soma® Safe Enclosure Bed admittedly looks imposing and confining.
  • The need for safe, less restrictive alternatives to the more traditional type of restraints.
  • The risks versus benefits of utilizing traditional restraints rather than the Soma® Safe Enclosure Bed.
  • Providing staff with a “hard wired” scripted response explaining to visitors or others
  • the rationale for the use of the bed and the benefits over traditional types of restraints.
  • Potential quality of life issues if a patient should sustain an injury as a result
  • of a fall rather than utilize a Soma® Safe Enclosure Bed.
  • The patient’s perception of being in a Soma® Safe Enclosure Bed.
  • The Soma® Safe Enclosure Bed as an appropriate intervention to contain sitter costs.

It has been our experience that with proper staff, physician, patient and family education the Soma® Safe Enclosure Bed is truly a safer and more humane alternative to other types of restraints. The Soma® Safe Enclosure Bed can be easily incorporated into the patient’s safety plan of care in conjunction with other safety devices such as bed and chair alarms to encourage the use of the least restrictive devices and minimize the risk of falls throughout the patient’s hospitalization.

As the Soma® Safe Enclosure Bed has become accepted in other areas of the organization there has been a decrease the organization’s overall sitter usage, accounting for thousands of dollars in staff overtime each pay period. Additionally, these sitters were being pulled from routine patient care assignments to 1:1 sitter assignments thereby increasing staffing shortages on the nursing units. The use of the Soma® Safe Enclosure Bed has eased this shortage on the units where it is utilized.

Lastly, we have found the Vivax Medical Corporation team to be extremely responsive to our customer service needs. Their understanding regarding the regulatory pressures and challenges that healthcare providers are faced with today and their willingness to do what ever it takes has continued to foster our loyalty to the product.

Candace L. Maffei, RN
Nurse Manager, Geriatric Psychiatric Unit

Griffin Hospital Study

The purpose of the Griffin Hospital study was to compare the current restraint system with the Soma® Safe Enclosure for agitated hospitalized patients. Aspects studied included the safety, length of stay, health care professional’s satisfaction, acceptability, ease of use, and comfort of the two types of restraint systems used in hospitalized patients.